GlassScriptPhysician profile
Nicole Stephens
NPI 1811580913
$15,363.43
in general payments reported to CMS, 2019-2025
78 companies · $3,643 in 2025
The $3,643 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,302 · 2022: $3,571 · 2023: $2,814 · 2024: $4,033 · 2025: $3,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,796 · Education: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,796.42 |
| Education | $693.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $1,032.32 | 2021-2025 | Adcetris, Tukysa |
| Pfizer INC. | $1,020.38 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $957.36 | 2021-2025 | Imfinzi, Enhertu, Calquence |
| Novartis Pharmaceuticals Corporation | $872.49 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $776.83 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Astellas Pharma US INC | $623.19 | 2021-2025 | Xtandi, Padcev, Vyloy |
| Eisai INC. | $600.55 | 2021-2025 | |
| Celgene Corporation | $570.18 | 2022-2025 | Reblozyl, Opdualag, Pomalyst |
| Genmab U.S., INC. | $535.44 | 2023-2025 | Epkinly |
| Daiichi Sankyo INC. | $461.85 | 2021-2025 | Enhertu, Injectafer |
| Amgen INC. | $456.64 | 2021-2024 | Kyprolis, Nplate, Vectibix |
| Lilly USA, LLC | $452.32 | 2021-2025 | Jaypirca, Retevmo, Verzenio |
| Gilead Sciences, INC. | $406.57 | 2022-2025 | Trodelvy |
| Incyte Corporation | $389.38 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Jazz Pharmaceuticals INC. | $374.80 | 2021-2025 |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $356.09 | 2022-2025 | Erleada, Rybrevant, Darzalex |
| E.R. Squibb & Sons, L.L.C. | $325.28 | 2022-2025 | Opdivo, Opdualag |
| Regeneron Healthcare Solutions, INC. | $311.42 | 2022-2025 | Libtayo, Lynozyfic |
| Takeda Pharmaceuticals U.S.A., INC. | $306.00 | 2021-2025 | Fruzaqla, Iclusig, Ninlaro |
| Emd Serono, INC. | $277.13 | 2022-2025 | |
| Sobi, INC | $275.68 | 2022-2025 | |
| Genentech USA, INC. | $213.26 | 2022-2025 | Polivy, Venclexta, Itovebi |
| Glaxosmithkline, LLC. | $172.48 | 2021-2025 | Ojjaara, Jemperli, Blenrep |
| Servier Pharmaceuticals LLC | $163.42 | 2021-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $157.11 | 2022-2023 | Imbruvica |
| Bayer Healthcare Pharmaceuticals INC. | $141.19 | 2021-2025 | |
| Tersera Therapeutics LLC | $135.72 | 2023-2025 | Quzyttir, Zoladex |
| Novocure INC. | $129.31 | 2024-2025 | Optune Lua (Novottf-200t) |
| Array Biopharma INC | $127.72 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Genzyme Corporation | $121.39 | 2022-2025 | |
| Abbvie INC. | $120.33 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $113.57 | 2022-2025 | Onivyde |
| Dendreon Pharmaceuticals LLC | $103.07 | 2025 | Provenge |
| Menarini Silicon Biosystems, INC. | $102.00 | 2025 | |
| Csl Behring | $99.88 | 2023-2024 | Idelvion, Afstyla, Hizentra |
| Mirati Therapeutics, INC. | $98.34 | 2023-2024 | Krazati |
| Pharmaessentia USA Corporation | $95.59 | 2024-2025 | Besremi |
| Karyopharm Therapeutics INC. | $93.40 | 2021-2025 | Xpovio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.11 | 2021-2025 | |
| Stemline Therapeutics INC. | $91.00 | 2023 | Orserdu |
| Agios Pharmaceuticals, INC. | $90.28 | 2023-2024 | Pyrukynd |
| Rigel Pharmaceuticals, INC. | $90.23 | 2022-2024 | Rezlidhia, Tavalisse |
| Apellis Pharmaceuticals, INC. | $86.57 | 2022-2024 | Empaveli |
| Caris Mpi, INC. | $79.54 | 2025 | Mi Cancer Seek |
| Tempus Ai, INC | $77.91 | 2024-2025 | Xt Cdx |
| Janssen Scientific Affairs, LLC | $77.77 | 2022-2023 | Pipeline, Rybrevant |
| Kyowa Kirin, INC. | $75.53 | 2021-2024 | Poteligeo |
| Taiho Oncology, INC. | $73.00 | 2022-2025 | |
| Kite Pharma, INC. | $72.40 | 2022-2023 | Yescarta |
| Epizyme, INC. | $59.13 | 2021-2022 | |
| G1 Therapeutics, INC. | $56.28 | 2022-2023 | Cosela |
| Octapharma USA, INC. | $52.67 | 2022-2023 | Panzyga, Octagam Immune Globulin (Human) |
| Aveo Pharmaceuticals, INC. | $50.87 | 2022-2024 | Fotivda |
| Amneal Pharmaceuticals LLC | $44.99 | 2023-2024 | Avastin, Neupogen, Neulasta |
| Beone Medicines USA, INC. | $44.33 | 2025 | Tevimbra, Brukinsa |
| Heron Therapeutics, INC. | $43.17 | 2022 | |
| Puma Biotechnology, INC. | $41.15 | 2021 | |
| Alexion Pharmaceuticals, INC. | $39.96 | 2023-2024 | Ultomiris |
| Pharmacosmos Therapeutics INC. | $38.59 | 2024 | Cosela |
| Morphosys, US INC. | $38.47 | 2022 | |
| Adc Therapeutics America, INC. | $31.07 | 2025 | |
| Immunocore Limited | $29.49 | 2025 | Kimmtrak |
| Coherus Oncology, INC. | $28.50 | 2024 | |
| Syndax Pharmaceuticals, INC. | $23.98 | 2025 | |
| Deciphera Pharmaceuticals INC. | $23.57 | 2022 | |
| Exelixis INC. | $22.89 | 2025 | Cabometyx |
| Novo Nordisk INC | $22.85 | 2021 | |
| Myriad Genetic Laboratories, INC. | $20.94 | 2025 | Myrisk |
| Medtronic, INC. | $19.58 | 2022 | |
| Geron Corporation | $18.61 | 2024 | Rytelo |
| Dova Pharmaceuticals | $18.07 | 2021 | |
| Ge Healthcare | $17.77 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.72 | 2022 | |
| Legend Biotech USA INC. | $17.68 | 2025 | Carvykti |
| Emmaus Medical, INC. | $17.12 | 2022 | |
| Blueprint Medicines Corporation | $17.11 | 2021 | |
| Foundation Medicine, INC. | $16.05 | 2021 | |
| Acrotech Biopharma INC. | $13.80 | 2022 |
Drugs and devices associated with these payments
Enhertu $517Keytruda $504Reblozyl $431Imfinzi $358Epkinly $331Xtandi $313Lenvima $301Kisqali $247Padcev $235Libtayo $210Inlyta $206Tukysa $194Fruzaqla $181Lynparza $180Ibrance $176Trodelvy $174Zepzelca $165Fabhalta $163Jakafi $146Adcetris $141Optune Lua (Novottf-200t) $129Calquence $127Pluvicto $124Erleada $114Imbruvica $113Elrexfio $111Lutathera $111Opdualag $110Rybrevant $110Verzenio $105Jaypirca $105Retevmo $105Provenge $103Cellsearch $102Krazati $98.34Besremi $95.59Bosulif $94.88Tibsovo $93.33Welireg $91.34Orserdu $91.00Mektovi $84.88Braftovi $84.88Scemblix $84.26Onivyde $82.70Ojjaara $80.92Mi Cancer Seek $79.54Monjuvi $78.99Xt Cdx $77.91Piqray $77.86Quzyttir $75.91Opdivo $75.84Venclexta $74.15Vonjo $68.42Lorbrena $67.06Iclusig $63.01Tasigna $60.85Zoladex $59.81Talzenna $56.60Zynyz $55.91Cosela $54.95Pyrukynd $53.25Paxlovid $52.93Empaveli $52.24Idelvion $51.03Afstyla $51.03Besponsa $50.45Doptelet $49.64Jevtana $46.13Polivy $45.44Avastin $44.99Nubeqa $44.61Tavalisse $42.32Rezlidhia $42.32Xpovio $41.31Pipeline $38.99Fotivda $37.34Poteligeo $36.17Darzalex $34.38Inqovi $34.25Lonsurf $34.25Yescarta $33.43Synagis $32.82Talvey $31.96Zynlonta $31.07Kimmtrak $29.49Elahere $28.55Ninlaro $28.01Lynozyfic $27.86Mekinist $27.46Injectafer $27.34Keytruda Qlex $27.31Tevimbra $26.80Jemperli $26.41Hizentra $26.39Blenrep $25.47Sarclisa $24.87Pemazyre $24.87Xofigo $24.45Itovebi $24.11Shingrix $23.76
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.